Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03167021
Other study ID # CHU-333
Secondary ID 2017-A00328-45
Status Completed
Phase N/A
First received May 11, 2017
Last updated July 5, 2017
Start date April 5, 2017
Est. completion date June 2, 2017

Study information

Verified date May 2017
Source University Hospital, Clermont-Ferrand
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The objective of this survey will be to evaluate the perception by the students (except for medical students, pharmacies) of community pharmacists concerning the management of cannabis consumption. We want to see if the student population perceives the pharmacist as the public health actor of choice, and if they would more easily turn to him or to another health professional (doctor, nurse) in case they need. Discussing possible problematic consumption or for a simple search for information. It will be assessed whether the pharmacist seems to be a good candidate and an element of choice when young adults want to take an intelligence approach to cannabis consumption.


Description:

This observational and transversal study will be conducted as a survey using the REDCap software and the response to this survey will be done online, in real time, with an automatic, secure and centralized data collection (CHU Clermont-Ferrand).

Students of the Auvergne Rhone Alpes region will be contacted by email thanks to the student associations and scholarity departments. Answer to the survey will be done online via the following link https://redcap.chu-clermontferrand.fr/surveys/?s=JMRF9FLRJP.


Recruitment information / eligibility

Status Completed
Enrollment 150
Est. completion date June 2, 2017
Est. primary completion date June 2, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Student following a university path in the Auvergne Rhone Alpes region

Exclusion Criteria:

- Medical student

- Pharmacy student

- age < 18-year

- Other than student

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Survey
This observational and transversal study will be conducted as a survey using the REDCap software and the response to this survey will be done online, in real time, with an automatic, secure and centralized data collection (CHU Clermont-Ferrand).

Locations

Country Name City State
France CHU Clermont-Ferrand Clermont-Ferrand Auvergne

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Role of health professionals in the prevention of cannabis addiction Students' perceptions (visual analogic scale) of the role of three types of health professionals (community pharmacists, general practitioners and academic health services) in the prevention of cannabis addiction at day 1
Secondary Role of health professionals for the therapeutic management of cannabis addiction Assessment of students' perceptions (visual analogic scale) of the role of three types of health professionals (community pharmacists, general practitioners and academic health services) for the therapeutic management of cannabis addiction. at day 1
Secondary Cannabis consumption yes/no at day 1
Secondary Type of cannabis used marijuana/haschich at day 1
Secondary Frequency of cannabis use at day 1
Secondary Sought effects of cannabis use Recreational / Stone / Therapeutic / Other expected effect at day 1
Secondary Level of knowledge on cannabis Yes I know the risk / No I don't know the risk at day 1
Secondary Consumption of cigarettes yes/no at day 1
Secondary Consumption of e-cigarettes yes/no at day 1
Secondary Consumption of alcohol yes/no at day 1
See also
  Status Clinical Trial Phase
Completed NCT03253926 - Effect of Lorcaserin on Cannabis Withdrawal and Self-administration Phase 1/Phase 2
Completed NCT04060602 - Personalized Feedback Intervention to Reduce Risky Cannabis Use. N/A
Completed NCT01212081 - Assessment of Cannabis Craving in Schizophrenia Using Virtual Reality
Recruiting NCT04988490 - Quantification of Cannabinoids and Comparison to Post-Surgical Pain Medication Requirements and Surgical Outcomes
Recruiting NCT05188404 - Aging and Marijuana: Benefits, Effects, and Risks
Completed NCT03662737 - VRT as a Biomarker of Cerebellar Dysfunction in Chronic Cannabis Use
Not yet recruiting NCT05999383 - Understanding the Clinical Pharmacology of Marijuana-Tobacco Co-administration Phase 2
Terminated NCT04436055 - Intergenerational Effects of Paternal Periconceptional Cannabis and Other Drug Use (EPIC)
Active, not recruiting NCT04374773 - Effects of Pregnancy-associated Hormones on THC Metabolism in Women Phase 4
Completed NCT04316741 - Brief Intervention Combined With Health Coaching Via Social Media for Cannabis Use N/A
Recruiting NCT05396638 - Characterization of Endocannabinoid and Endogenous Opioid Levels in Adolescents With Cannabis Use Disorder N/A
Recruiting NCT05309226 - Cannabis Use in Pregnancy and Downstream Effects on Maternal and Infant Health
Recruiting NCT03859089 - Cannabis for Opioid Substitution Trial
Recruiting NCT05849636 - Alerta Cannabis: Evaluation of Web-based Tailored Intervention N/A
Enrolling by invitation NCT05521321 - Feasibility and Acceptability of the Cannabis Awareness and Prevention Toolkit N/A
Recruiting NCT05119244 - Environment and Lung Cancer N/A
Recruiting NCT04841655 - Tobacco Cessation Among Smokers Under Alcohol and/or Cannabis Treatment
Terminated NCT04100590 - Eye Tracking as a Biomarker of Cannabis Effects Phase 2
Completed NCT05167097 - Mindsets and the Effectiveness of a Brief Intervention - Replication N/A
Recruiting NCT04114903 - Exploring the Anti-inflammatory Properties of Cannabis and Their Relevance to Insulin Sensitivity